Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 183
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

Can low carbohydrate ketogenic diets inhibit cancers?

Insulin is a hormone which supports growth of normal cells, but also of cancers. A very low carbohydrate...

Open Insulin

A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

Backer Badge Funded